Application of microtiter solid-phase radioimmunoassay to the determination of hepatitis B e antigen. 1979

Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi

Microtiter solid-phase radioimmunoassay (micro-SPRIA) was applied to the detection of hepatitis B e antigen (HBeAg) in the serum. Antibody against HBeAg to coat the microtiter plate and for radiolabeling was obtained from the serum of asymptomatic carriers of hepatitis B surface antigen by an affinity column of partially purified HBeAg. The micro-SPRIA was sensitive and could be performed without prior concentration of the test serum. HBeAg was detected in 21 (35%) out of 60 serum samples positive for hepatitis B surface antigen, all of which were negative by the conventional immunodiffusion method even after they had been concentrated threefold.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
October 1973, Applied microbiology,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
February 1976, Journal of immunology (Baltimore, Md. : 1950),
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
June 1973, JAMA,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
April 1981, The Journal of allergy and clinical immunology,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
December 1984, Radioisotopes,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
March 1974, Vox sanguinis,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
June 1973, Lancet (London, England),
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
March 1982, JAMA,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
October 1979, Klinische Wochenschrift,
Y Miyakawa, and F Tsuda, and Y Akahane, and M Mayumi
January 1975, Transfusion,
Copied contents to your clipboard!